Research Funded To Date
The Ben and Catherine Ivy Foundation is dedicated to finding a cure for brain cancer. We strive in improve the quality of life and increase the life expectancy of those diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
Since 2008, we have funded 36 separate institutions with over 114 different research grants totaling over $165 million. These grants have involved research in phase 0 clinical trials, biomarkers, genomics, imaging, immunotherapy, stem cell, vaccines, and the development of possible new drugs.
2012
IVY NEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN THE NEUROLOGICAL SCIENCES.
PI: Brandy Wells
Director, Public Affairs and Education
Translational Genomics Research Institute (TGen)
AN INTEGRATED APPROACH UTILIZING LARGE-SCALE CHEMICAL SCREENS TO IDENTIFY THERAPEUTIC AGENTS AGAINST TUMOR INITIATING CELLS DERIVED FROM INDIVIDUAL PATIENTS. CANDIDATES ARE EVALUATED IN VIVO IN MATCHING PATIENT-DERIVED XENOGRAFT MODELS TO ALLOW PATIENT-SPECIFIC THERAPEUTIC AGENTS.
PI: Greg D. Foltz, M.D.
Director, The Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment
Swedish Medical Center